179 related articles for article (PubMed ID: 36580829)
1. Synthetic mRNA rescues very long-chain acyl-CoA dehydrogenase deficiency in patient fibroblasts and a murine model.
Zhao XJ; Mohsen AW; Mihalik S; Solo K; Aliu E; Shi H; Basu S; Kochersperger C; Van't Land C; Karunanidhi A; Coughlan KA; Siddiqui S; Rice LM; Hillier S; Guadagnin E; Giangrande PH; Martini PGV; Vockley J
Mol Genet Metab; 2023 Jan; 138(1):106982. PubMed ID: 36580829
[TBL] [Abstract][Full Text] [Related]
2. Tissue-specific strategies of the very-long chain acyl-CoA dehydrogenase-deficient (VLCAD-/-) mouse to compensate a defective fatty acid β-oxidation.
Tucci S; Herebian D; Sturm M; Seibt A; Spiekerkoetter U
PLoS One; 2012; 7(9):e45429. PubMed ID: 23024820
[TBL] [Abstract][Full Text] [Related]
3. Characterization of exonic variants of uncertain significance in very long-chain acyl-CoA dehydrogenase identified through newborn screening.
D'Annibale OM; Koppes EA; Sethuraman M; Bloom K; Mohsen AW; Vockley J
J Inherit Metab Dis; 2022 May; 45(3):529-540. PubMed ID: 35218577
[TBL] [Abstract][Full Text] [Related]
4. Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders.
Djouadi F; Aubey F; Schlemmer D; Ruiter JP; Wanders RJ; Strauss AW; Bastin J
Hum Mol Genet; 2005 Sep; 14(18):2695-703. PubMed ID: 16115821
[TBL] [Abstract][Full Text] [Related]
5. Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse.
Cox KB; Hamm DA; Millington DS; Matern D; Vockley J; Rinaldo P; Pinkert CA; Rhead WJ; Lindsey JR; Wood PA
Hum Mol Genet; 2001 Sep; 10(19):2069-77. PubMed ID: 11590124
[TBL] [Abstract][Full Text] [Related]
6. Long-term correction of very long-chain acyl-coA dehydrogenase deficiency in mice using AAV9 gene therapy.
Keeler AM; Conlon T; Walter G; Zeng H; Shaffer SA; Dungtao F; Erger K; Cossette T; Tang Q; Mueller C; Flotte TR
Mol Ther; 2012 Jun; 20(6):1131-8. PubMed ID: 22395529
[TBL] [Abstract][Full Text] [Related]
7. One potential hotspot ACADVL mutation in Chinese patients with very-long-chain acyl-coenzyme A dehydrogenase deficiency.
Li X; Ma R; Liu Y; Kang L; He R; Song J; Ren J; Li Y; Huang M; Men J; Yang Y
Clin Chim Acta; 2020 Apr; 503():218-222. PubMed ID: 31794763
[TBL] [Abstract][Full Text] [Related]
8. Messenger RNA rescues medium-chain acyl-CoA dehydrogenase deficiency in fibroblasts from patients and a murine model.
Zhao XJ; Mohsen AW; Mihalik S; Solo K; Basu S; Aliu E; Shi H; Kochersberger C; Karunanidhi A; Van't Land C; Coughlan KA; Siddiqui S; Rice LM; Hillier S; Guadagnin E; DeAntonis C; Giangrande PH; Martini PGV; Vockley J
Hum Mol Genet; 2023 Jul; 32(14):2347-2356. PubMed ID: 37162351
[TBL] [Abstract][Full Text] [Related]
9. In vitro characterization and in vivo expression of human very-long chain acyl-CoA dehydrogenase.
Merritt JL; Matern D; Vockley J; Daniels J; Nguyen TV; Schowalter DB
Mol Genet Metab; 2006 Aug; 88(4):351-8. PubMed ID: 16621643
[TBL] [Abstract][Full Text] [Related]
10. A heterozygous missense mutation in adolescent-onset very long-chain acyl-CoA dehydrogenase deficiency with exercise-induced rhabdomyolysis.
Hisahara S; Matsushita T; Furuyama H; Tajima G; Shigematsu Y; Imai T; Shimohama S
Tohoku J Exp Med; 2015 Apr; 235(4):305-10. PubMed ID: 25843429
[TBL] [Abstract][Full Text] [Related]
11. Very long-chain acyl-CoA dehydrogenase (VLCAD-) deficiency-studies on treatment effects and long-term outcomes in mouse models.
Tucci S
J Inherit Metab Dis; 2017 May; 40(3):317-323. PubMed ID: 28247148
[TBL] [Abstract][Full Text] [Related]
12. Clinical and biochemical outcome of patients with very long-chain acyl-CoA dehydrogenase deficiency.
Rovelli V; Manzoni F; Viau K; Pasquali M; Longo N
Mol Genet Metab; 2019 May; 127(1):64-73. PubMed ID: 31031081
[TBL] [Abstract][Full Text] [Related]
13. Genetic basis for correction of very-long-chain acyl-coenzyme A dehydrogenase deficiency by bezafibrate in patient fibroblasts: toward a genotype-based therapy.
Gobin-Limballe S; Djouadi F; Aubey F; Olpin S; Andresen BS; Yamaguchi S; Mandel H; Fukao T; Ruiter JP; Wanders RJ; McAndrew R; Kim JJ; Bastin J
Am J Hum Genet; 2007 Dec; 81(6):1133-43. PubMed ID: 17999356
[TBL] [Abstract][Full Text] [Related]
14. Treatment of VLCAD-Deficient Patient Fibroblasts with Peroxisome Proliferator-Activated Receptor δ Agonist Improves Cellular Bioenergetics.
D'Annibale OM; Phua YL; Van't Land C; Karunanidhi A; Dorenbaum A; Mohsen AW; Vockley J
Cells; 2022 Aug; 11(17):. PubMed ID: 36078043
[No Abstract] [Full Text] [Related]
15. Familial very long chain acyl-CoA dehydrogenase deficiency as a cause of neonatal sudden infant death: improved survival by prompt diagnosis.
Scalais E; Bottu J; Wanders RJ; Ferdinandusse S; Waterham HR; De Meirleir L
Am J Med Genet A; 2015 Jan; 167A(1):211-4. PubMed ID: 25338548
[TBL] [Abstract][Full Text] [Related]
16. Biochemical correction of very long-chain acyl-CoA dehydrogenase deficiency following adeno-associated virus gene therapy.
Merritt JL; Nguyen T; Daniels J; Matern D; Schowalter DB
Mol Ther; 2009 Mar; 17(3):425-9. PubMed ID: 19156135
[TBL] [Abstract][Full Text] [Related]
17. Molecular and cellular pathology of very-long-chain acyl-CoA dehydrogenase deficiency.
Schiff M; Mohsen AW; Karunanidhi A; McCracken E; Yeasted R; Vockley J
Mol Genet Metab; 2013 May; 109(1):21-7. PubMed ID: 23480858
[TBL] [Abstract][Full Text] [Related]
18. Tissue carnitine homeostasis in very-long-chain acyl-CoA dehydrogenase-deficient mice.
Spiekerkoetter U; Tokunaga C; Wendel U; Mayatepek E; Ijlst L; Vaz FM; van Vlies N; Overmars H; Duran M; Wijburg FA; Wanders RJ; Strauss AW
Pediatr Res; 2005 Jun; 57(6):760-4. PubMed ID: 15774826
[TBL] [Abstract][Full Text] [Related]
19. Novel ACADVL variants resulting in mitochondrial defects in long-chain acyl-CoA dehydrogenase deficiency.
Chen T; Tong F; Wu XY; Zhu L; Yi QZ; Zheng J; Yang RL; Zhao ZY; Cang XH; Shu Q; Jiang PP
J Zhejiang Univ Sci B; 2020 Nov.; 21(11):885-896. PubMed ID: 33150772
[TBL] [Abstract][Full Text] [Related]
20. AAV9 gene replacement therapy for respiratory insufficiency in very-long chain acyl-CoA dehydrogenase deficiency.
Zieger M; Keeler AM; Flotte TR; ElMallah MK
J Inherit Metab Dis; 2019 Sep; 42(5):870-877. PubMed ID: 30993714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
